Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

Clinical trial NCT00089999 · COMPLETED

Trial details

NCT number: NCT00089999
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2004-06-01
Primary completion: 2008-03-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.